SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-20-036790
Filing Date
2020-08-05
Accepted
2020-08-05 16:05:52
Documents
14
Period of Report
2020-08-05
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K flxn-8k_20200805.htm   iXBRL 8-K 40061
2 EX-99.1 flxn-ex991_7.htm EX-99.1 110486
3 GRAPHIC gpcfa35qvgf3000001.jpg GRAPHIC 126974
  Complete submission text file 0001564590-20-036790.txt   467504

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA flxn-20200805.xsd EX-101.SCH 5804
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE flxn-20200805_lab.xml EX-101.LAB 19469
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE flxn-20200805_pre.xml EX-101.PRE 11651
7 EXTRACTED XBRL INSTANCE DOCUMENT flxn-8k_20200805_htm.xml XML 3555
Mailing Address 10 MALL ROAD SUITE 301 BURLINGTON MA 01803
Business Address 10 MALL ROAD SUITE 301 BURLINGTON MA 01803 (781) 305-7777
Flexion Therapeutics Inc (Filer) CIK: 0001419600 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36287 | Film No.: 201077249
SIC: 2834 Pharmaceutical Preparations